1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States Stem Cell Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States Stem Cell Market
4. United States Stem Cell Market by
Type
4.1. Adult Stem Cell
4.2. Induced Pluripotent Stem Cell
4.3. Human Embryonic Stem Cell
4.4. Other Types
5. United States Stem Cell Market by
Application
5.1. Regenerative Medicine
5.2. Neurology
5.3. Oncology
5.4. Cardiology
5.5. Other Application
6. United States Stem Cell Market by
End User
6.1. Therapeutics Companies
6.2. Cell and Tissue Banks
6.3. Tools and Reagents Companies
6.4. Service Companies
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5
1. Report Overview
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Challenges
3.3. PEST-Analysis
3.4. Porter's Diamond Model for the United States Stem Cell Market
3.5. IGR-Growth Matrix Analysis
3.6. Competitive Landscape in the United States Stem Cell Market
4. United States Stem Cell Market by
Type
4.1. Adult Stem Cell
4.2. Induced Pluripotent Stem Cell
4.3. Human Embryonic Stem Cell
4.4. Other Types
5. United States Stem Cell Market by
Application
5.1. Regenerative Medicine
5.2. Neurology
5.3. Oncology
5.4. Cardiology
5.5. Other Application
6. United States Stem Cell Market by
End User
6.1. Therapeutics Companies
6.2. Cell and Tissue Banks
6.3. Tools and Reagents Companies
6.4. Service Companies
7. Company Profiles
7.1. Company 1
7.2. Company 2
7.3. Company 3
7.4. Company 4
7.5. Company 5